StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.45−0.05 (-3.33%)

Close on Nov 18, 2026Market cap $21.92MP/E –Yield –

CervoMed pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

CervoMed's pe ratio was 58.5× on Jul 31, 2018.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2018Jul 31, 201858.5×−7.9
2014Jan 31, 201466.4×+0.0
2013Dec 31, 201366.4×–

More CervoMed figures

See a number that looks wrong?